Zystor

About:

ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal

Website: http://www.zystor.com

Top Investors: Venture Investors, State of Wisconsin Investment Board, Stonehenge Capital, Mason Wells, Prolog Ventures

Description:

ZyStor Therapeutics, Inc. is a privately-held biotechnology company developing enzyme replacement therapies for the treatment of lysosomal storage diseases.